During the past decade, Mountain Kidney & Hypertension Associates conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountain Kidney & Hypertension Associates" #1 sponsor was "Keryx Biopharmaceuticals" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Ardelyx" with 2 trials sponsored, "Chinook Therapeutics U.S., Inc." with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountain Kidney & Hypertension Associates" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator and "Medstar Health Research Institute" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Mountain Kidney & Hypertension Associates" are "Chronic Kidney Disease" (4 trials), "Diabetic Kidney Disease" (4 trials), "Chronic Kidney Diseases" (3 trials), "Alport Syndrome" (2 trials) and "Autosomal Dominant Polycystic Kidney" (2 trials). Many other conditions were trialed in "Mountain Kidney & Hypertension Associates" in a lesser frequency.

Most popular intervention types in "Mountain Kidney & Hypertension Associates" are "Drug" (19 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Atrasentan" (2 trials), "GCS-100" (2 trials), "Advance care planning coaching session." (1 trials) and "Bardoxolone methyl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mountain Kidney & Hypertension Associates" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Mountain Kidney & Hypertension Associates". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Mountain Kidney & Hypertension Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mountain Kidney & Hypertension Associates, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".